Guo Yubiao, Xie Canmao, Rodriguez R Michael, Light Richard W
Department of Pulmonary Medicine, First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.
Respirology. 2005 Jun;10(3):378-84. doi: 10.1111/j.1440-1843.2005.00715.x.
The purpose of this retrospective study was to identify factors associated with recurrent spontaneous pneumothorax (SP) in southern China, and to compare the therapeutic effectiveness of different procedures.
A total of 182 consecutive patients (89.0% male; mean age, 38.9 years), admitted with their first episode of pneumothorax, were reviewed retrospectively. Follow up was available in 138 patients (75.8%), including 68 treated by chemical pleurodesis and 70 by chest tube drainage alone. The cumulative recurrence rates with different therapeutic procedures and different chemical sclerosing agents were compared, and the factors that influenced the recurrence rate were analysed using Cox's proportional hazard model.
The most common pre-existing lung disease responsible for pneumothorax was COPD (69.7%), followed by tuberculosis (16.5%). Recurrence was significantly more common in taller patients, patients with lower weight, and patients with secondary spontaneous pneumothorax. The cumulative recurrence rates in the pleurodesis therapy group after 6 months, 1 and 3 years were 13, 16 and 27%, respectively, whereas in the chest tube drainage group the recurrence rates were 26, 33 and 50%, respectively (P < 0.05). There was no significant difference in the recurrence rate for those receiving tetracycline compared with those who received gentamicin.
Spontaneous pneumothorax patients who are taller, weigh less or have secondary spontaneous pneumothorax are more likely to have recurrences. The risk of recurrence is reduced in patients who undergo chemical pleurodesis. Since there was no significant difference between intrapleural tetracycline and gentamicin, gentamicin should be considered as a potential chemical sclerosing agent.
本回顾性研究旨在确定中国南方复发性自发性气胸(SP)的相关因素,并比较不同治疗方法的疗效。
回顾性分析182例首次因气胸入院的连续患者(男性占89.0%;平均年龄38.9岁)。138例患者(75.8%)获得随访,其中68例接受化学性胸膜固定术治疗,70例仅接受胸腔闭式引流。比较不同治疗方法和不同化学硬化剂的累积复发率,并使用Cox比例风险模型分析影响复发率的因素。
导致气胸最常见的基础肺部疾病是慢性阻塞性肺疾病(COPD,69.7%),其次是肺结核(16.5%)。复发在身材较高、体重较轻以及继发性自发性气胸患者中更为常见。胸膜固定术治疗组6个月、1年和3年的累积复发率分别为13%、16%和27%,而胸腔闭式引流组的复发率分别为26%、33%和50%(P<0.05)。接受四环素治疗的患者与接受庆大霉素治疗的患者复发率无显著差异。
身材较高、体重较轻或患有继发性自发性气胸的自发性气胸患者更易复发。接受化学性胸膜固定术的患者复发风险降低。由于胸腔内注射四环素和庆大霉素之间无显著差异,庆大霉素应被视为一种潜在的化学硬化剂。